DrMcPharma

Disease Prevention, the USPSTF, and Top Recommendations for Individual HealthMyHealthFinderHealthCheckUS Preventive Services Task Force

The Current State of Science in the United States Since January 1st, 2025Executive SummarySince the beginning of 2025, the scientific landscape in the United States has been marked by significant advancements across various disciplines, alongside notable shifts in funding and policy. Breakthroughs in medicine have seen progress in gene therapy for previously intractable conditions, the development of promising cancer vaccines and targeted therapies, and the increasing integration of artificial

Recently Approved Antibiotics (2023-2024)| Drug Name | Approval Date (YYYY-MM) | Mechanism of Action | Indication(s) | Snippet ID(s) ||---|---|---|---|---|| Pivya (pivmecillinam) | 2024-04 | Inhibits bacterial cell wall synthesis | Uncomplicated urinary tract infections (UTI) in adult women | || Orlynvah (sulopenem etzadroxil and probenecid) | 2024-10 | Oral penem antibiotic | Uncomplicated UTI caused by E. coli, Klebsiella pneumoniae, or P. mirabilis in adult women with limited or no alternative

Return on investment in biomedical science in the United States